BioTech

ChemoMetec Appoints Price As CFO, Nikolajsen To Resign

August 03, 2026 — 05:07 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - ChemoMetec A/S, a biotechnology company, on Saturday announced the appointment on Phillip Massie Price as the new Chief Financial Officer (CFO), effective from August 3, 2026.

Price most recently served as Director of Corporate Finance at Unimed, a healthcare group. He previously held the position of Interim Group CFO at LiqTech International Inc., where he led Group Finance.

The company's Board stated that it had arrived at an agreement with current CFO Kim Nicolajsen regarding the succession. Nicolajsen, appointed in July 2024, will resign from the position at the same time as Price takes over.

Together with CEO Martin Helbo Behrens, Price will form the executive management team of the company.

CHEMM.CO is currently trading at DKK 414, down 4.30% on the Copenhagen Stock Exchange.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

BioTech

Latest Articles
Data is currently not available